1: Guthmann JP, Arlt D, Garcia LM, Rosales M, Jesus Sanchez J, Alvarez E, Lonlas S, Conte M, Bertoletti G, Fournier C, Huari R, Torreele E, Llanos-Cuentas A. Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru. Trop Med Int Health. 2005 Sep;10(9):856-62. 

2: Yardley V, Croft SL, DE Doncker S, Dujardin JC, Koirala S, Rijal S, Miranda C, Llanos-Cuentas A, Chappuis F.The sensivity of clinical isolates of leishmania from Peru and Nepal to Miltefosine. Am J Trop Med Hyg. 2005 Aug;73(2):272-275. 

3: Miranda-Verastegui C, Llanos-Cuentas A, Arevalo I, Ward BJ, Matlashewski G. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis. 2005 May 15;40(10):1395-403. Epub 2005 Apr 7. 

4: Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. Am J Trop Med Hyg. 2005 Feb;72(2):133-7. 

5: de Wet N, Llanos-Cuentas A, Suleiman J, Baraldi E, Krantz EF, Della Negra M, Diekmann-Berndt H. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. Clin Infect Dis. 2004 Sep 15;39(6):842-9. Epub 2004 Aug 27. 

6:  Soto Tarazona A, Solari Zerpa L, Mendoza Requena D, Llanos-Cuentas A, Magill A. Evaluation of the rapid diagnostic test OptiMAL for diagnosis of malaria due to Plasmodium vivax. Braz J Infect Dis. 2004 Apr;8(2):151-5. Epub 2004 Sep 8. 

7: Garcia L, Kindt A, Bermudez H, Llanos-Cuentas A, De Doncker S, Arevalo J, Wilber Quispe Tintaya K, Dujardin JC.Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes. J Clin Microbiol. 2004 May;42(5):2294-7. 

8: Chinga-Alayo E, Huarcaya E, Nasarre C, del Aguila R, Llanos-Cuentas A. The influence of climate on the epidemiology of bartonellosis in Ancash, Peru. Trans R Soc Trop Med Hyg. 2004 Feb;98(2):116-24. 

9: Reithinger R, Canales Espinoza J, Llanos-Cuentas A, Davies CR. Domestic dog ownership: a risk factor for human infection with Leishmania (Viannia) species.Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):141-5. 

10: Victoir K, De Doncker S, Cabrera L, Alvarez E, Arevalo J, Llanos-Cuentas A, Le Ray D, Dujardin JC. Direct identification of Leishmania species in biopsies from patients with American tegumentary leishmaniasis. Trans R Soc Trop Med Hyg. 2003 Jan-Feb;97(1):80-7. 

11: Guthmann JP, Llanos-Cuentas A, Palacios A, Hall AJ.  Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop Med Int Health. 2002 Jun;7(6):518-25. 

 12:  Guthmann JP, Hall AJ, Jaffar S, Palacios A, Lines J, Llanos-Cuentas A. Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru. Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):577-83. 

13:  Arevalo I, Ward B, Miller R, Meng TC, Najar E, Alvarez E, Matlashewski G, Llanos-Cuentas A. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis. 2001 Dec 1;33(11):1847-51. Epub 2001 Oct 23. 

14:  Llanos-Cuentas A, Campos P, Clendenes M, Canfield CJ, Hutchinson DB. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru. Braz J Infect Dis. 2001 Apr;5(2):67-72. 

15: Davies CR, Llanos-Cuentas EA, Campos P, Monge J, Leon E, Canales J. Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):631-6.